Navigation Links
Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance
Date:2/3/2009

Oncotype DX and advance our pipeline, while continuing to move the organization toward profitability," said Brad Cole, Chief Operating and Financial Officer of Genomic Health. "To achieve these goals, we expect that the majority of our anticipated annual net loss will be realized in the first half of the year as we continue to invest in our product pipeline, U.S. sales force expansion and worldwide commercial infrastructure."

The Company is providing the following financial guidance for the full year ending December 31, 2009:

    -- Test results delivered of 50,000 to 53,000
    -- Revenue of $148 million to $160 million
    -- Net loss of $7 million to $14 million


    Recent Highlights and Accomplishments

    Commercial Progress

    -- More than 39,600 test results delivered for the full year of 2008, an
       increase of 62 percent, compared with 24,450 test results delivered in
       2007.  In the fourth quarter of 2008 more than 10,580 test results were
       delivered, an increase of 47 percent, compared with more than 7,200
       test results delivered in the same period in 2007.
    -- More than 85,000 Oncotype DX test results have been delivered as of
       December 31, 2008.
    -- In 2008, gained coverage through contracts, policies and agreements for
       an additional 56 million U.S. lives for the Oncotype DX breast cancer
       assay, bringing the total U.S. lives covered to more than 90 percent
       for appropriate node-negative breast cancer patients.
    -- Established a contract with the Blue Cross Blue Shield (BCBS)
       Association, which we believe will lead to additional coverage with
       non-contracted BCBS plans.
    -- Oncotype DX remains the only multi-gene expression assay to be
       recommended by both the National Comprehensive Cancer Network (NCCN)
       and American Society of Clinical Oncology (ASCO) in their respective
       Breast Cancer Treatment Gui
'/>"/>
SOURCE Genomic Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Enrichment of Genomic Loci for Targeted Sequencing Application Is Focus of 2009 AGBT Conference Workshop
2. Complete Genomics to Release Its DNA Sequencing Data for the First Time at Advances in Genome Biology and Technology Annual Meeting
3. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
4. Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum
5. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
6. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
7. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
8. AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
9. Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
10. Transgenomic Receives Accreditation From College of American Pathologists
11. Genomic Health Announces Appointment of Ginger Graham to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 19, 2014 Naurex Inc., a ... drugs for diseases of the central nervous system, today ... chief executive officer, will present at the 33 rd ... will take place at 3:00 p.m. PST on Tuesday, ... San Francisco, Calif. ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources ... will grow at a 12 percent compound annual growth ... of the aging population and the increasing adoption of ... America will also spur demand for dental ... dental implant and periodontal treatments. Other key ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 Today, ... locate its pilot production facility and future company ... and produce innovative new materials that safely and ... not only because of its historic, strong support ... efforts to attract leading edge, technology-based companies such ...
(Date:12/19/2014)... Reports from CDC show approximately ... one or more chronic health conditions - including cardiovascular ... some of these diseases, but may not eliminate the ... While implanted nerve stimulation devices today offer relief, they ... can induce side effects. , To eliminate the ...
Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2
... Calif., June 3 Ingenuity Systems, the,leading provider ... signing of a four year agreement with Boehringer ... used throughout the,Boehringer Ingelheim research and development organization ... a general tool for biological search,and exploration., ...
... N.C. -- Microscopic robots crafted to maneuver separately without ... after years of continuing research led by a Duke ... to do assembly and control at this fine a ... Donald, a Duke professor of computer science and biochemistry. ...
... 2 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) ... data,for its FDA-approved diabetes drugs, BYETTA(R) (exenatide) injection ... and,obesity drug candidates at the American Diabetes Association,s ... Francisco, CA from June 6 to,10. The company ...
Cached Biology Technology:Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim 2Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 2Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 4Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 5Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 6Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 7
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... for killer diseases such as HIV/AIDS, TB, Malaria, Chagas ... is despite the fact that these diseases mainly affect ... is inhibitive due to lack of economic demand. Researchers ... of some vaccines and diagnostics) would increase if more ...
... hand-in-hand with enlargement of a brain region that handles negative ... Texas Veterans Health Care System have found. , ... and contains more nerve cells in humans who carry the ... regions that receive input from the pulvinar are more strongly ...
... have limited lifespans, which means that they must be ... into the blood cell types needed by the body. ... Molecular Biology Laboratory (EMBL) unit in Monterotondo, Italy, in ... the University of Lund in Sweden, have now uncovered ...
Cached Biology News:Increase in drug development for killer diseases is not enough 2Gene linked with mental illness shapes brain region, researchers find 2Lost in the labyrinth 2
... SpeedVac™ Concentrators set the standard for sample concentration ... with large chamber uses a combination of centrifugal ... in a single run. , SC210A comes equipped ... for long lasting chemical compatibility ...
Digital display of time, vacuum and temperature , Dual vacuum control of ramping rate and ultimate level , Comes complete with RH40-12 (40 x 1.5 ml) Rotor and (2) Glass Condensation Flasks. ...
... series of vacuum concentrators/centrifugal evaporators offers a ... to rapid and safe concentration of heat-labile ... with oil-free or high vacuum pumps, a ... selection of rotors (eliminating sample loss by ...
... George Paxinos Affiliation: School of Psychology, The University ... Affiliation: Curtin University of Technology, Perth, Australia This ... of the rat brain. It is a ... revison and extension of the compact 3rd edition. ...
Biology Products: